AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Agilon Stockholders and Encourages Investors to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Agilon Health, Inc. for possible violations of federal securities laws following significant leadership changes and a withdrawal of earnings guidance, which led to a sharp decline in the company's stock price [2][3]. Group 1: Company Developments - On August 4, 2025, Agilon Health, Inc. announced the resignation of its President, CEO, and Board Director, Steven Sell, which surprised the market [3]. - The company also released its second-quarter 2025 financial results and withdrew its previously issued full-year 2025 earnings guidance, contributing to a more than 27% drop in share price during after-hours trading [3]. Group 2: Legal Investigation - The investigation by Bragar Eagel & Squire focuses on whether Agilon failed to disclose material information regarding the leadership transition and guidance withdrawal, potentially violating federal securities laws [2][3]. - Investors who suffered losses due to these developments are encouraged to contact the law firm to discuss their legal rights and options [4].